pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
NL77315.078.21
Approved · small molecule · Patients with coronary artery disease and an indication for PCI
NL77315.078.21 for Patients with coronary artery disease and an indication for PCI is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code NL77315.078.21
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Patients with coronary artery disease and an indication for PCI
- Status
- active
- Trials
- 1